Briacell Therapeutics Corp (BCTX) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Apr 30 2026 to Apr 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Briacell Therapeutics Corp   (NASDAQ: BCTX)


Briacell Therapeutics's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Briacell Therapeutics's ROI in the third quarter of 2026?
Briacell Therapeutics Corp recorded a cumulative net loss of $-31 million during 12 months ending in the third quarter of 2026, resulting in a negative return on investment (ROI) of -166.51%.

Within the Healthcare sector 694 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 3239 to 3788.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Apr 30 2026)
III. Quarter		 (Jan 31 2026)
II. Quarter		 (Oct 31 2025)
I. Quarter		 (Jul 31 2025)
IV. Quarter		 (Apr 30 2025)
III. Quarter
Y / Y Investment Change TTM 248.87 % 667.45 % 40.61 % 40.2 % -59.22 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 23 21 9 21 12
Return On Investment (TTM) -166.51 % -187.92 % -260.3 % -262.04 % -368.32 %
BCTX's Overall Ranking # 3788 # 3239 # 3880 # 3879 # 4180
Seq. Investment Change TTM 16.67 % 43.09 % 9.95 % 90.05 % 156.66 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -31 -30 -29 -27 -20

BCTX Company Profile >> Back to BCTX Roi Comparisons >> See Annual BCTX Return On Investment



Return On Investment BCTX's Ranking
Within: No.
Industry # 324
Sector # 695
Overall # 3788

Return On Investment Statistics
High Average Low
195.05 %
-220.77 %
-763.89 %
(Jul 31 2022)   (Jan 31 2025)







Financial Statements
Briacell Therapeutics's III. Quarter Investments $ 23 Millions BCTX's Balance sheet
Briacell Therapeutics's III. Quarter Income $ -7 Millions Quarterly BCTX's Income Statement
BCTX's Income by Division See BCTX's Income by Division


BCTX Annual Return On Investment (Jul 31 2025)
2025		 (Jul 31 2024)
2024		 (Jul 31 2023)
2023		 (Jul 31 2022)
2022		 (Jul 31 2021)
2021
Total Investments in Millions 21 2 25 10 28
Y / Y Investment Growth 951.6 % -92.06 % 144.84 % -62.58 % -
Net Income in Millions -27 -5 -20 -27 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment -125.11 % -244.32 % -79.91 % -258.63 % -1.54 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BCTX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BCTX's Competitors
Subscribers only: Roi for Briacell Therapeutics's Suppliers
Subscribers only: Return On Investment for BCTX's Customers

Other Ratios
BCTX's Roa BCTX's Inventory Turnover Ratio BCTX's Growth Rates BCTX's Dividend Statistics
BCTX's Profitability Ratios BCTX's Asset Turnover Ratio BCTX's Dividend Growth
BCTX's Roe BCTX's Valuation Ratios BCTX's Financial Strength Ratios BCTX's Dividend Payout Ratio



Companies with similar Return On Investment at Apr 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:42:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.